Honghong Wang

Honghong Wang

Auto-generated profile, based on publicly available information

Honghong Wang

Department of Pathophysiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Genome Research
Verified
Journal Article
Open access
PDF file
CLConghui Li
Conghui Li
HWHonghong Wang
Honghong Wang
ZYZhinang Yin
Zhinang Yin
PFPingping Fang
Pingping Fang
RXRuijing Xiao
Ruijing Xiao
KLKaiwei Liang
Kaiwei Liang
G-quadruplexes (G4s) are noncanonical DNA secondary structures formed through the self-association of guanines, and G4s are distributed widely across the genome. G4 participates in multiple biological processes including gene transcription, and G4-targeted ligands serve as potential therapeutic agents for DNA-targeted therapies. However, genome-wide studies of the exact roles of G4s in transcriptional regulation are still lacking. Here, we establish a sensitive G4-CUT&Tag method for genome-wide profiling of native G4s with high resolution and specificity. We find that native G4 signals are cell type–specific and are associated with transcriptional regulatory elements carrying active epigenetic modifications. Drug-induced promoter-proximal RNA polymerase II pausing promotes nearby G4 formation. In contrast, G4 stabilization by G4-targeted ligands globally reduces RNA polymerase II occupancy at gene promoters as well as nascent RNA synthesis. Moreover, ligand-induced G4 stabilization modulates chromatin states and impedes transcription initiation via inhibition of general transcription factors loading to promoters. Together, our study reveals a reciprocal genome-wide regulation between native G4 dynamics and gene transcription, which will deepen our understanding of G4 biology toward therapeutically targeting G4s in human diseases.

19 February 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
KWKang Wang
Kang Wang
HWHonghong Wang
Honghong Wang
CLConghui Li
Conghui Li
ZYZhinang Yin
Zhinang Yin
RXRuijing Xiao
Ruijing Xiao
KLKaiwei Liang
Kaiwei Liang
An R loop is a unique triple-stranded structure that participates in multiple key biological processes and is relevant to human diseases. Accurate and comprehensive R loop profiling is a prerequisite for R loops studies. However, current R loop mapping methods generate large discrepancies, therefore an independent method is in urgent need. Here, we establish an independent R loop CUT&Tag (Tn5-based cleavage under targets and tagmentation) method by combining CUT&Tag and GST-His6-2×HBD (glutathione S-transferase–hexahistidine–2× hybrid-binding domain), an artificial DNA-RNA hybrid sensor that specifically recognizes the DNA-RNA hybrids. We demonstrate that the R loop CUT&Tag is sensitive, reproducible, and convenient for native R loop mapping with high resolution, and find that the capture strategies, instead of the specificity of sensors, largely contribute to the disparities among different methods. Together, we provide an independent strategy for genomic profiling of native R loops and help resolve discrepancies among multiple R loop mapping methods.

16 August 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
XZXiaotong Zhang
Xiaotong Zhang
SWShan Wang
Shan Wang
XCXuanyin Chen
Xuanyin Chen
ZCZhongxue Cui
Zhongxue Cui
XLXue’eR Li
Xue’eR Li
QWQiushi Wang
Qiushi Wang

19 May 2023 in Science Advances
Verified
Journal Article
Open access
MQMin Qiu
Min Qiu
ZYZhinang Yin
Zhinang Yin
HWHonghong Wang
Honghong Wang
LLLingyu Lei
Lingyu Lei
CLConghui Li
Conghui Li
KLKaiwei Liang
Kaiwei Liang
Cyclin-dependent kinase 12 (CDK12) interacts with cyclin K to form a functional nuclear kinase that promotes processive transcription elongation through phosphorylation of the C-terminal domain of RNA polymerase II (Pol II). To gain a comprehensive understanding of CDK12's cellular function, we used chemical genetic and phosphoproteomic screening to identify a landscape of nuclear human CDK12 substrates, including regulators of transcription, chromatin organization, and RNA splicing. We further validated LEO1, a subunit of the polymerase-associated factor 1 complex (PAF1C), as a bona fide cellular substrate of CDK12. Acute depletion of LEO1, or substituting LEO1 phosphorylation sites with alanine, attenuated PAF1C association with elongating Pol II and impaired processive transcription elongation. Moreover, we discovered that LEO1 interacts with and is dephosphorylated by the Integrator-PP2A complex (INTAC) and that INTAC depletion promotes the association of PAF1C with Pol II. Together, this study reveals an uncharacterized role for CDK12 and INTAC in regulating LEO1 phosphorylation, providing important insights into gene transcription and its regulation.

31 March 2023 in Science Advances
Verified
Journal Article
Closed access
DWDonghai Wang
Donghai Wang
ZYZhinang Yin
Zhinang Yin
HWHonghong Wang
Honghong Wang
LWLiyuan Wang
Liyuan Wang
TLTianyu Li
Tianyu Li
GQGuoliang Qing
Guoliang Qing
MYCN amplification in neuroblastoma leads to aberrant expression of MYCN oncoprotein, which binds active genes promoting transcriptional amplification. Yet, how MYCN coordinates transcription elongation to meet productive transcriptional amplification and which elongation machinery represents MYCN-driven vulnerability remain to be identified. We conducted a targeted screen of transcription elongation factors and identified the super elongation complex (SEC) as a unique vulnerability in MYCN -amplified neuroblastomas. MYCN directly binds EAF1 and recruits SEC to enhance processive transcription elongation. Depletion of EAF1 or AFF1/AFF4, another core subunit of SEC, leads to a global reduction in transcription elongation and elicits selective apoptosis of MYCN -amplified neuroblastoma cells. A combination screen reveals SEC inhibition synergistically potentiates the therapeutic efficacies of FDA-approved BCL-2 antagonist ABT-199, in part due to suppression of MCL1 expression, both in MYCN -amplified neuroblastoma cells and in patient-derived xenografts. These findings identify disruption of the MYCN-SEC regulatory axis as a promising therapeutic strategy in neuroblastoma.

9 October 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JLJiaxu Liu
Jiaxu Liu
YFYingzhe Fang
Yingzhe Fang
RFRongrong Fan
Rongrong Fan
HWHonghong Wang
Honghong Wang
HHHao Huang
Hao Huang
GQGuoliang Qing
Guoliang Qing
Concurrent chromosomal 17q-gain and MYCN amplification define a subset of neuroblastoma associated with particularly adverse clinical outcomes. However, how these genetic alterations synergize to promote tumor progression and whether their cooperation confers therapeutic vulnerabilities remain elusive. We herein performed a CRISPR-based functional screen targeting 17q-gain genes and identified the RNA m 6 A reader IGF2BP1 as a critical MYCN collaborator to promote aggressive neuroblastomas via activation of phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), a key enzyme involved in de novo purine biosynthesis. Rewiring of PAICS-mediated nucleotide metabolism enabled tumor cells to sustain necessary purine pools for productive transcription of replicative stress-responsive genes, including CHK1 , to cope with the exacerbated replication stress. Pharmacological inhibition of CHK1 elicited a robust immune reprogramming, leading to activation of cGAS–STING signaling, upregulation of Major Histocompatibility Complex class I expression, and synergistic tumor suppression with immune checkpoint blockade. Altogether, we identify an IGF2BP1/MYCN–PAICS–CHK1 axis that drives aggressive neuroblastoma phenotypes and constitutes an actionable vulnerability for therapeutic intervention.